Global Health (MEDANTA) Share Price Rises 2.59% to Rs 1,292.65 Today

Global Health Share Price rose 2.59% on 28 October 2026. The stock was trading at Rs 1,292.65 as of 10:22:56 AM IST, against a previous close of Rs 1,260.00, a gain of Rs 32.65 per share. At this level the market capitalisation of Global Health stands at Rs 32,485.78 crore, according to latest Univest data.

Global Health operates in the Hospital & Healthcare Services industry within the Healthcare sector. Univest figures confirm the price action, but they do not point to a specific company trigger. That leaves the numbers to tell the story: where the stock sits inside today's range, how its valuation compares with the industry, and what the reported ratios say about the business behind the share price rise.

Global Health Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,292.65
Previous Close	Rs 1,260
Today's Move	Rs 32.65 (+2.59%)
Open	Rs 1,272
High	Rs 1,293
Low	Rs 1,245.1
Market Capitalisation	Rs 32,485.78 crore
Market Cap Category	Large Cap

Global Health Ltd. (MEDANTA) rose to Rs 1,292.65 from the previous close of Rs 1,260, a move of Rs 32.65 or 2.59%. The stock opened at Rs 1,272, reached a high of Rs 1,293, recorded a low of Rs 1,245.1.

Global Health Share Price Today stands at Rs 1,292.65, up Rs 32.65 or 2.59% from the previous close of Rs 1,260.00. The stock opened at Rs 1,272.00, touched a low of Rs 1,245.10 and a high of Rs 1,293.00. The open was Rs 12.00 above the previous close, the day low was Rs 14.90 below it, and the last traded price sits just Rs 0.35 below the day's high.

The price table under this heading lists each level. The day's range from Rs 1,245.10 to Rs 1,293.00 is Rs 47.90 wide, and the current price sits at the very top of it. The distance between the day low and the day high shows how far the stock moved within the session so far, and the gain of Rs 32.65 is measured against the previous close of Rs 1,260.00.

Because the trading session was still open when this Global Health Share Price Update was written, these levels can change as trading continues. The 2.59% move is the verified fact of the day, and this article does not guess at a reason for it. What the price data establishes is the size of the move and its position inside the range.

A rising price tells only part of the story, so the next step is to look at the ratios that describe the business itself. The fundamentals below show how the valuation and returns behind the Global Health stock price rise compare with the industry.

Global Health Ltd. (MEDANTA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 32,485.78 crore
P/E Ratio	60.91x
P/B Ratio	8.24x
ROE	15.12%
ROCE	19.38%
EPS	Rs 20.69
Book Value Per Share	Rs 152.93
Dividend Yield	0.04%

Global Health Ltd. (MEDANTA) fundamental metrics show P/E 60.91x, P/B 8.24x, ROE 15.12%, ROCE 19.38%. Taken on their own, these numbers offer context rather than a trading signal.

Global Health Ltd. has a market capitalisation of Rs 32,485.78 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 60.91x, P/B at 8.24x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.12% and ROCE of 19.38%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.69, book value per share of Rs 152.93, dividend yield of 0.04%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 42.8x, median ROE of 13.07%, median ROCE of 15.7%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	60.91x
Benchmark Median P/E	42.8x
Benchmark Average P/E	92.61x
Benchmark P/E Range	6.78x to 1,522.98x
Company P/B Ratio	8.24x
Benchmark Median P/B	3.56x
Company ROE	15.12%
Benchmark Median ROE	13.07%
Company ROCE	19.38%
Benchmark Median ROCE	15.7%
Company Market Capitalisation	Rs 32,485.78 crore
Benchmark Median Market Cap	Rs 509.38 crore

Global Health Ltd. (MEDANTA) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.

Global Health Ltd. (MEDANTA) has a P/E ratio of 60.91x, which is above the benchmark median of 42.8x, a difference of +42.31%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Global Health Ltd. (MEDANTA) has a ROE of 15.12%, which is above the benchmark median of 13.07%, a difference of +15.68%. Global Health Ltd. (MEDANTA) has a ROCE of 19.38%, which is above the benchmark median of 15.7%, a difference of +23.44%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Apollo Hospitals Enterprise Ltd.	APOLLOHOSP	1,12,367.71	53.67	11.58	23.54	21.73
MANIPAL HEALTH ENTERPRI L	MANIPALHOS	82,013.77	94.72	5.09	12.95	13.93
Max Healthcare Institute Ltd.	MAXHEALTH	81,271.41	56.65	7.55	14.53	14.97
Aster DM Healthcare Ltd.	ASTERDM	56,501.81	181.8	13.7	13.07	16.22
Fortis Healthcare Ltd.	FORTIS	55,338.43	53.53	5.52	11.32	14.07

Global Health Ltd. (MEDANTA) has a P/E ratio of 60.91x compared with the displayed peer median of 56.65x. The comparison is relative and should not be read as a recommendation. Its ROE of 15.12% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 19.38% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Global Health Ltd. (MEDANTA) has a market capitalisation of Rs 32,485.78 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Global Health

• Price action: the stock rose 2.59% to Rs 1,292.65 from a previous close of Rs 1,260.00 and trades close to its day high.
• Valuation: a P/E of 60.91 compares with an industry median of 42.80, while the P/B of 8.24 compares with a median of 3.56.
• Returns: ROE of 15.12% and ROCE of 19.38% sit above the industry medians of 13.07% and 15.70%.
• Per-share data: EPS of Rs 20.69, book value of Rs 152.93 and a dividend yield of 0.04% give the base for the valuation multiples.
• Sector position: market capitalisation of Rs 32,485.78 crore is above the industry median of Rs 509.38 crore across 66 companies.

About Global Health

Global Health Ltd. is a company in the Hospital & Healthcare Services industry, part of the Healthcare sector. Hospital and healthcare services businesses sit in the part of the economy that provides medical care and related services.

This note therefore sticks to the sector and industry classification and the reported ratios. For Global Health company news and later financial results, readers can follow the stock page on Univest.

Frequently Asked Questions

Why is Global Health share price rising today?

Ans. Univest figures confirm the price action, but they do not point to a specific company trigger. The stock traded at Rs 1,292.65, up 2.59% from the previous close of Rs 1,260.00, with market capitalisation at Rs 32,485.78 crore.

What is the Global Health share price today?

Ans. Global Health share price was last at Rs 1,292.65 as of 28 October 2026 at 10:22:56 AM IST. That is a gain of Rs 32.65, or 2.59%, over the previous close of Rs 1,260.00.

What is the market capitalisation of Global Health?

Ans. Global Health market cap stands at Rs 32,485.78 crore at the current price of Rs 1,292.65. The industry median across 66 companies is Rs 509.38 crore, so the company sits well above that median.

What is the P/E ratio of Global Health?

Ans. The P/E ratio of Global Health is 60.91. The industry median is 42.80 and the average is 92.61, so the multiple sits above the median and below the average. The range across 58 companies with a P/E runs from 6.78 to 1,522.98.

What are the ROE and ROCE of Global Health?

Ans. Global Health reports ROE of 15.12% and ROCE of 19.38%. The industry median ROE is 13.07% and median ROCE is 15.70%, so both returns sit above the benchmark medians for the same industry.

What are the EPS and book value of Global Health?

Ans. EPS is Rs 20.69 and book value per share is Rs 152.93. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share. The stock trades at a P/B ratio of 8.24.

Does Global Health pay a dividend?

Ans. According to latest Univest data, the dividend yield of Global Health is 0.04%. Dividend yield is historical data relating the payout to the current price, and it is not a guarantee of any future payout by the company.

How does Global Health compare with its peers?

Ans. Global Health has a P/E of 60.91 against peers between 53.53 and 181.80, and ROE of 15.12% against peers between 11.32% and 23.54%. Its market cap of Rs 32,485.78 crore is below each of the five peers shown.

Track Global Health Share Price on Univest

Use Global Health Ltd. (MEDANTA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Univest lets users track the live Global Health Share Price, fundamental ratios such as P/E, P/B, ROE and ROCE, 52-week levels and wider market insights in one place. The stock page carries the latest price, day range and valuation metrics, and the Univest peer pages make it simple to compare Global Health with other Hospital & Healthcare Services names. All of this is information, not advice.